As of 2026-03-21, the Relative Valuation of Emergent BioSolutions Inc (EBS) is 27.27 USD. This relative valuation is based on P/E multiples. With the latest stock price at 8.19 USD, the upside of Emergent BioSolutions Inc based on Relative Valuation is 233.0%.
The range of the Relative Valuation is 24.19 - 30.20 USD.
| Range | Selected | |
| Trailing P/E multiples | 19.4x - 20.6x | 20.0x |
| Forward P/E multiples | 16.5x - 17.9x | 17.2x |
| Fair Price | 24.19 - 30.20 | 27.27 |
| Upside | 195.4% - 268.8% | 233.0% |
| Date | P/E |
| 2026-03-19 | 5.51 |
| 2026-03-18 | 5.46 |
| 2026-03-17 | 5.51 |
| 2026-03-16 | 5.68 |
| 2026-03-13 | 5.50 |
| 2026-03-12 | 5.55 |
| 2026-03-11 | 5.58 |
| 2026-03-10 | 5.72 |
| 2026-03-09 | 5.70 |
| 2026-03-06 | 5.65 |
| 2026-03-05 | 5.76 |
| 2026-03-04 | 5.98 |
| 2026-03-03 | 6.08 |
| 2026-03-02 | 6.13 |
| 2026-02-27 | 5.56 |
| 2026-02-26 | 7.57 |
| 2026-02-25 | 7.51 |
| 2026-02-24 | 7.48 |
| 2026-02-23 | 7.47 |
| 2026-02-20 | 7.46 |
| 2026-02-19 | 7.50 |
| 2026-02-18 | 7.35 |
| 2026-02-17 | 7.30 |
| 2026-02-13 | 7.39 |
| 2026-02-12 | 7.40 |
| 2026-02-11 | 7.52 |
| 2026-02-10 | 7.53 |
| 2026-02-09 | 7.52 |
| 2026-02-06 | 7.45 |
| 2026-02-05 | 7.19 |
| 2026-02-04 | 7.78 |
| 2026-02-03 | 7.87 |
| 2026-02-02 | 7.99 |
| 2026-01-30 | 7.73 |
| 2026-01-29 | 8.12 |
| 2026-01-28 | 7.99 |
| 2026-01-27 | 8.34 |
| 2026-01-26 | 8.12 |
| 2026-01-23 | 8.15 |
| 2026-01-22 | 8.25 |
| 2026-01-21 | 7.84 |
| 2026-01-20 | 7.57 |
| 2026-01-16 | 7.50 |
| 2026-01-15 | 7.47 |
| 2026-01-14 | 8.55 |
| 2026-01-13 | 8.30 |
| 2026-01-12 | 8.45 |
| 2026-01-09 | 8.84 |
| 2026-01-08 | 9.11 |
| 2026-01-07 | 9.48 |